vs
Side-by-side financial comparison of CuriosityStream Inc. (CURI) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $19.2M, roughly 2.0× CuriosityStream Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -161.8%, a 142.1% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 35.8%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-71.3M).
Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CURI vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $19.2M | $38.3M |
| Net Profit | $-3.8M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | -17.6% | -169.0% |
| Net Margin | -19.7% | -161.8% |
| Revenue YoY | 35.8% | 407.0% |
| Net Profit YoY | -34.6% | -4.7% |
| EPS (diluted) | $-0.07 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $38.3M | ||
| Q3 25 | $18.4M | $32.1M | ||
| Q2 25 | $19.0M | $26.4M | ||
| Q1 25 | $15.1M | $16.5M | ||
| Q4 24 | $14.1M | $7.6M | ||
| Q3 24 | $12.6M | $6.1M | ||
| Q2 24 | $12.4M | — | ||
| Q1 24 | $12.0M | — |
| Q4 25 | $-3.8M | $-61.9M | ||
| Q3 25 | $-3.7M | $-67.3M | ||
| Q2 25 | $784.0K | $-92.6M | ||
| Q1 25 | $319.0K | $-129.6M | ||
| Q4 24 | $-2.8M | $-59.2M | ||
| Q3 24 | $-3.1M | $-85.7M | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-5.0M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -17.6% | -169.0% | ||
| Q3 25 | -24.5% | -173.5% | ||
| Q2 25 | 2.5% | -269.8% | ||
| Q1 25 | 0.5% | -390.1% | ||
| Q4 24 | -27.4% | -919.0% | ||
| Q3 24 | -25.8% | -1314.3% | ||
| Q2 24 | -20.6% | — | ||
| Q1 24 | -30.4% | — |
| Q4 25 | -19.7% | -161.8% | ||
| Q3 25 | -20.4% | -209.8% | ||
| Q2 25 | 4.1% | -350.3% | ||
| Q1 25 | 2.1% | -784.9% | ||
| Q4 24 | -19.9% | -783.4% | ||
| Q3 24 | -24.3% | -1404.0% | ||
| Q2 24 | -16.4% | — | ||
| Q1 24 | -42.0% | — |
| Q4 25 | $-0.07 | $-0.06 | ||
| Q3 25 | $-0.06 | $-0.07 | ||
| Q2 25 | $0.01 | $-0.10 | ||
| Q1 25 | $0.01 | $-0.15 | ||
| Q4 24 | $-0.05 | $-0.08 | ||
| Q3 24 | $-0.06 | $-0.14 | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.3M | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $41.5M | $-500.5M |
| Total Assets | $75.7M | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.3M | $242.8M | ||
| Q3 25 | $27.8M | $257.8M | ||
| Q2 25 | $28.1M | $153.7M | ||
| Q1 25 | $33.4M | $61.6M | ||
| Q4 24 | $32.1M | $149.8M | ||
| Q3 24 | $33.2M | $130.4M | ||
| Q2 24 | $39.5M | — | ||
| Q1 24 | $38.8M | — |
| Q4 25 | $41.5M | $-500.5M | ||
| Q3 25 | $47.2M | $-524.3M | ||
| Q2 25 | $49.8M | $-570.7M | ||
| Q1 25 | $58.1M | $-591.4M | ||
| Q4 24 | $57.8M | $-489.1M | ||
| Q3 24 | $62.2M | $-745.1M | ||
| Q2 24 | $64.8M | — | ||
| Q1 24 | $67.0M | — |
| Q4 25 | $75.7M | $501.9M | ||
| Q3 25 | $74.7M | $519.0M | ||
| Q2 25 | $78.7M | $402.1M | ||
| Q1 25 | $85.3M | $303.8M | ||
| Q4 24 | $86.2M | $382.9M | ||
| Q3 24 | $87.6M | $364.6M | ||
| Q2 24 | $90.9M | — | ||
| Q1 24 | $94.6M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $-70.4M |
| Free Cash FlowOCF − Capex | $3.9M | $-71.3M |
| FCF MarginFCF / Revenue | 20.5% | -186.2% |
| Capex IntensityCapex / Revenue | 0.1% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | $-70.4M | ||
| Q3 25 | $4.4M | $-68.9M | ||
| Q2 25 | $2.8M | $-79.7M | ||
| Q1 25 | $1.9M | $-85.9M | ||
| Q4 24 | $3.0M | $-85.1M | ||
| Q3 24 | $2.3M | $-98.8M | ||
| Q2 24 | $2.2M | — | ||
| Q1 24 | $666.0K | — |
| Q4 25 | $3.9M | $-71.3M | ||
| Q3 25 | — | $-69.6M | ||
| Q2 25 | — | $-80.8M | ||
| Q1 25 | $1.8M | $-87.0M | ||
| Q4 24 | — | $-87.3M | ||
| Q3 24 | — | $-101.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 20.5% | -186.2% | ||
| Q3 25 | — | -217.2% | ||
| Q2 25 | — | -305.9% | ||
| Q1 25 | 12.2% | -526.9% | ||
| Q4 24 | — | -1155.4% | ||
| Q3 24 | — | -1663.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.1% | 2.4% | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | 0.0% | 4.1% | ||
| Q1 25 | 0.5% | 6.8% | ||
| Q4 24 | 0.0% | 28.0% | ||
| Q3 24 | 0.0% | 45.7% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.